uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NASDAQ NASDAQ · IDXX

Idexx Laboratories

$504.70 -$1.82 -0.36% CLOSE 09.11.26 AFTER HOURS $504.70

Convergence score

3.9 / 5.0 BULLISH

+0.0 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$714.95 +41.7%

Range $470.00 — $830.00

Sector

Health Care

NASDAQ · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

3.9

/ 5.0

BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

3.8

Multi-signal aggregate How CSR works →

Day Range

$500.61 – $510.90

52W Range

$500.61 – $769.98

Volume

401.6K

Avg Vol

621.2K

Mkt Cap

$39.81B

P/E

35.47

EPS (TTM)

$14.23

Div Yield

—

Beta

1.54

Today's convergence

Convergence score sits at 3.9 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

BULLISH

Last close

$504.70

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$747+48.0% Buy

Long term

12–36 MO

$282.53-44.0% Overvalued

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$714.95 +41.7%

RANGE $470.00 — $830.00

Analyst consensus

Consensus rating Buy

Blended score 3.9 / 5

Analysts tracked 37

Open analysts →

Financials

Key metrics

LATEST

P/E

35.47

EPS (TTM)

$14.23

Mkt Cap

$39.81B

Div Yield

—

Beta

1.54

52W Range

$500.61 – $769.98

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$747 +48.0%

RANGE $670 – $830

$670NOW $504.70$830

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$282.53 -44.0%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 35.47	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $909.37M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 3.9 3 37

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $470.00 $714.95 $700.00 $830.00 +41.7%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 4 10 9 0 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

8/27/2026

Firm

Weiss Ratings

Action

Downgrade

Rating

Hold (C+) ➝ Hold (C)

Target

—

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$506.53

Open

$509.88

Day Low

$500.61

Day High

$510.90

Bid

$554.21

Ask

$501.77

52W Low

$500.61

52W High

$769.98

50D Avg

$556.71

200D Avg

$604.57

Volume

401.6K

Avg Vol

621.2K

10D Avg Vol

508.3K

52W Change

-21.00%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

35.47

P/E (Fwd)

30.15

PEG (Fwd)

2.82

P/S

8.74

P/B

24.69

Book Value

$20.45

EV/Revenue

8.96

EV/EBITDA

25.16

Mkt Cap

39.81B

Enterprise Val

40.8B

Profitability & returns 6 FIELDS

Profit Margin

25.03%

Gross Margin

62.45%

Operating Margin

34.98%

EBITDA Margin

35.62%

Return on Assets

27.09%

Return on Equity

74.21%

Growth 3 FIELDS

Revenue Growth (YoY)

9.70%

Earnings Growth (YoY)

17.60%

Earnings Growth (Q)

15.10%

Balance sheet & cash flow 11 FIELDS

Total Revenue

4.55B

EBITDA

1.62B

Total Cash

196.93M

Total Debt

1.1B

Cash / Share

$2.50

Revenue / Share

$57.17

Free Cash Flow

909.37M

Operating CF

1.37B

Debt / Equity

67.97

Current Ratio

1.17

Quick Ratio

0.73

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

78.88M

Float

78.5M

Shares Short

2.09M

% Short of Float

3.04%

Short Ratio

3.41

% Held Insiders

0.22%

% Held Institutions

96.74%

Calendar & events 5 FIELDS

Next Earnings

2026-11-02

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-06-30

Last Split

2:1

Split Date

2015-06-16

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

11,000